SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001206774-06-000397
Filing Date
2006-03-09
Accepted
2006-03-09 14:47:18
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K bc71797.htm 10-K 836762
2 EXHIBIT 23 bc71797ex23.htm EX-23 3857
3 EXHIBIT 31.1 bc71797ex311.htm EX-31.1 14660
4 EXHIBIT 31.2 bc71797ex312.htm EX-31.2 14688
5 EXHIBIT 32.1 bc71797ex321.htm EX-32.1 3773
6 EXHIBIT 32.2 bc71797ex322.htm EX-32.2 3770
  Complete submission text file 0001206774-06-000397.txt   878922
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1220
Type: 10-K | Act: 34 | File No.: 000-23186 | Film No.: 06675827
SIC: 2836 Biological Products, (No Diagnostic Substances)